Integrated Care Systems present the biggest shake-up in medicines funding and decision-making in over a decade. As medicines, prescribing, pharmacy, finance and commissioning teams enter unchartered waters – there is much to discuss about this new reality of shared accountability, new funding flows, patient-centred decision-making and collaboration.

With change comes an opportunity to challenge medicines optimisation, value and how it can be utilised as an enabler for pathway transformation and improved patient outcomes.

The HSJ ICS Medicines Forum will bring together senior leaders responsible for establishing the new medicines and prescribing operating framework across the ICS. Through interactive panel discussions and roundtables, this event will facilitate an exchange of strategy and approach – and examine the opportunities to optimise value and patient outcomes in this new environment.

Key themes:

• Funding flows and decision-making in the ICS
• Driving value and measures outcomes through an integrated approach
• New responsibilities and accountabilities for Specialised Commissioning
• Optimising access to innovative medicines
• Developing the ICS medicines and prescribing workforce
• The opportunities of Population Health Management and addressing health inequalities through effective prescribing 
• Digitising medicines management